Skip to main content
Top
Published in: BMC Gastroenterology 1/2010

Open Access 01-12-2010 | Research article

African-American inflammatory bowel disease in a Southern U.S. health center

Authors: Hemanth Veluswamy, Kunal Suryawala, Ankur Sheth, Shannon Wells, Erik Salvatierra, Walter Cromer, Ganta V Chaitanya, Annette Painter, Mihir Patel, Kenneth Manas, Ellenmarie Zwank, Moheb Boktor, Kondal Baig, Balaji Datti, Michael J Mathis, Alireza Minagar, Paul A Jordan, Jonathan S Alexander

Published in: BMC Gastroenterology | Issue 1/2010

Login to get access

Abstract

Background

Inflammatory Bowel Diseases (IBD) remain significant health problems in the US and worldwide. IBD is most often associated with eastern European ancestry, and is less frequently reported in other populations of African origin e.g. African Americans ('AAs'). Whether AAs represent an important population with IBD in the US remains unclear since few studies have investigated IBD in communities with a majority representation of AA patients. The Louisiana State University Health Sciences Center in Shreveport (LSUHSC-S) is a tertiary care medical center, with a patient base composed of 58% AA and 39% Caucasian (W), ideal for evaluating racial (AA vs. W) as well and gender (M vs. F) influences on IBD.

Methods

In this retrospective study, we evaluated 951 visits to LSUHSC-S for IBD (between 2000 to 2008) using non-identified patient information based on ICD-9 medical record coding (Crohn's disease 'CD'-555.0- 555.9 and ulcerative colitis 'UC'-556.0-556.9).

Results

Overall, there were more cases of CD seen than UC. UC and CD affected similar ratios of AA and Caucasian males (M) and females (F) with a rank order of WF > WM > AAF > AAM. Interestingly, in CD, we found that annual visits per person was the highest in AA M (10.7 ± 1.7); significantly higher (* -p < 0.05) than in WM (6.3 ± 1.0). Further, in CD, the female to male (F: M) ratio in AA was significantly higher (*- p < 0.05) (1.9 ± 0.2) than in Caucasians (F:M = 1.3 ± 0.1) suggesting a female dominance in AACD; no differences were seen in UC F: M ratios.

Conclusion

Although Caucasians still represent the greatest fraction of IBD (~64%), AAs with IBD made up >1/3 (36.4%) of annual IBD cases from 2000-2008 at LSUHSC-S. Further studies on genetic and environments risks for IBD risk in AAs are needed to understand differences in presentation and progression in AAs and other 'non-traditional' populations.
Appendix
Available only for authorised users
Literature
1.
go back to reference Colombel JF, Watson AJ, Neurath MF: The 10 remaining mysteries of inflammatory bowel disease. Gut. 2008, 57: 429-433. 10.1136/gut.2007.122192.CrossRefPubMed Colombel JF, Watson AJ, Neurath MF: The 10 remaining mysteries of inflammatory bowel disease. Gut. 2008, 57: 429-433. 10.1136/gut.2007.122192.CrossRefPubMed
2.
go back to reference Bouma G, Xia B, Crusius JB, Bioque G, Koutroubakis I, von Blomberg BM, et al: Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin Exp Immunol. 1996, 103: 391-396. 10.1111/j.1365-2249.1996.tb08292.x.CrossRefPubMedPubMedCentral Bouma G, Xia B, Crusius JB, Bioque G, Koutroubakis I, von Blomberg BM, et al: Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin Exp Immunol. 1996, 103: 391-396. 10.1111/j.1365-2249.1996.tb08292.x.CrossRefPubMedPubMedCentral
3.
go back to reference Corrao G, Tragnone A, Caprilli R, Trallori G, Papi C, Andreoli A, et al: Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC). Int J Epidemiol. 1998, 27: 397-404. 10.1093/ije/27.3.397.CrossRefPubMed Corrao G, Tragnone A, Caprilli R, Trallori G, Papi C, Andreoli A, et al: Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC). Int J Epidemiol. 1998, 27: 397-404. 10.1093/ije/27.3.397.CrossRefPubMed
4.
go back to reference Osborne MJ, Stansby GP: Cigarette smoking and its relationship to inflammatory bowel disease: a review. J R Soc Med. 1992, 85: 214-216.PubMedPubMedCentral Osborne MJ, Stansby GP: Cigarette smoking and its relationship to inflammatory bowel disease: a review. J R Soc Med. 1992, 85: 214-216.PubMedPubMedCentral
5.
go back to reference Ruyssers NE, De Winter BY, De Man JG, Loukas A, Herman AG, Pelckmans PA, et al: Worms and the treatment of inflammatory bowel disease: are molecules the answer?. Clin Dev Immunol. 2008, 2008: 567314-CrossRefPubMedPubMedCentral Ruyssers NE, De Winter BY, De Man JG, Loukas A, Herman AG, Pelckmans PA, et al: Worms and the treatment of inflammatory bowel disease: are molecules the answer?. Clin Dev Immunol. 2008, 2008: 567314-CrossRefPubMedPubMedCentral
6.
go back to reference Fiocchi C: Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998, 115: 182-205. 10.1016/S0016-5085(98)70381-6.CrossRefPubMed Fiocchi C: Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998, 115: 182-205. 10.1016/S0016-5085(98)70381-6.CrossRefPubMed
7.
go back to reference Loftus EV: Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004, 126: 1504-1517. 10.1053/j.gastro.2004.01.063.CrossRefPubMed Loftus EV: Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004, 126: 1504-1517. 10.1053/j.gastro.2004.01.063.CrossRefPubMed
8.
go back to reference Mayberry J, Mann R: Inflammatory bowel disease in rural sub-Saharan Africa: rarity of diagnosis in patients attending mission hospitals. Digestion. 1989, 44: 172-176. 10.1159/000199907.CrossRefPubMed Mayberry J, Mann R: Inflammatory bowel disease in rural sub-Saharan Africa: rarity of diagnosis in patients attending mission hospitals. Digestion. 1989, 44: 172-176. 10.1159/000199907.CrossRefPubMed
9.
go back to reference Saeed SA, Crandall WV: Managing Crohn disease in children and adolescents : focus on tumor necrosis factor antagonists. Paediatr Drugs. 2008, 10: 31-38. 10.2165/00148581-200810010-00004.CrossRefPubMed Saeed SA, Crandall WV: Managing Crohn disease in children and adolescents : focus on tumor necrosis factor antagonists. Paediatr Drugs. 2008, 10: 31-38. 10.2165/00148581-200810010-00004.CrossRefPubMed
10.
11.
go back to reference Al-Nakib B, Radhakrishnan S, Jacob GS, Al-Liddawi H, Al-Ruwaih A: Inflammatory bowel disease in Kuwait. Am J Gastroenterol. 1984, 79: 191-194.PubMed Al-Nakib B, Radhakrishnan S, Jacob GS, Al-Liddawi H, Al-Ruwaih A: Inflammatory bowel disease in Kuwait. Am J Gastroenterol. 1984, 79: 191-194.PubMed
12.
go back to reference Yang SK, Loftus EV, Sandborn WJ: Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis. 2001, 7: 260-270. 10.1097/00054725-200108000-00013.CrossRefPubMed Yang SK, Loftus EV, Sandborn WJ: Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis. 2001, 7: 260-270. 10.1097/00054725-200108000-00013.CrossRefPubMed
13.
14.
go back to reference Zaahl MG, Winter TA, Warnich L, Kotze MJ: The -237C-->T promoter polymorphism of the SLC11A1 gene is associated with a protective effect in relation to inflammatory bowel disease in the South African population. Int J Colorectal Dis. 2006, 21: 402-408. 10.1007/s00384-005-0019-z.CrossRefPubMed Zaahl MG, Winter TA, Warnich L, Kotze MJ: The -237C-->T promoter polymorphism of the SLC11A1 gene is associated with a protective effect in relation to inflammatory bowel disease in the South African population. Int J Colorectal Dis. 2006, 21: 402-408. 10.1007/s00384-005-0019-z.CrossRefPubMed
15.
go back to reference Calkins BM, Lilienfeld AM, Garland CF, Mendeloff AI: Trends in incidence rates of ulcerative colitis and Crohn's disease. Dig Dis Sci. 1984, 29: 913-920. 10.1007/BF01312480.CrossRefPubMed Calkins BM, Lilienfeld AM, Garland CF, Mendeloff AI: Trends in incidence rates of ulcerative colitis and Crohn's disease. Dig Dis Sci. 1984, 29: 913-920. 10.1007/BF01312480.CrossRefPubMed
16.
go back to reference Eidelwein AP, Thompson R, Fiorino K, Abadom V, Oliva-Hemker M: Disease presentation and clinical course in black and white children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2007, 44: 555-560. 10.1097/MPG.0b013e3180335bb3.CrossRefPubMed Eidelwein AP, Thompson R, Fiorino K, Abadom V, Oliva-Hemker M: Disease presentation and clinical course in black and white children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2007, 44: 555-560. 10.1097/MPG.0b013e3180335bb3.CrossRefPubMed
17.
go back to reference White JM, O'Connor S, Winter HS, Heyman MB, Kirschner BS, Ferry GD, et al: Inflammatory bowel disease in African American children compared with other racial/ethnic groups in a multicenter registry. Clin Gastroenterol Hepatol. 2008, 6: 1361-1369. 10.1016/j.cgh.2008.07.032.CrossRefPubMedPubMedCentral White JM, O'Connor S, Winter HS, Heyman MB, Kirschner BS, Ferry GD, et al: Inflammatory bowel disease in African American children compared with other racial/ethnic groups in a multicenter registry. Clin Gastroenterol Hepatol. 2008, 6: 1361-1369. 10.1016/j.cgh.2008.07.032.CrossRefPubMedPubMedCentral
18.
go back to reference Mahid SS, Mulhall AM, Gholson RD, Eichenberger MR, Galandiuk S: Inflammatory bowel disease and African Americans: a systematic review. Inflamm Bowel Dis. 2008, 14: 960-967. 10.1002/ibd.20389.CrossRefPubMed Mahid SS, Mulhall AM, Gholson RD, Eichenberger MR, Galandiuk S: Inflammatory bowel disease and African Americans: a systematic review. Inflamm Bowel Dis. 2008, 14: 960-967. 10.1002/ibd.20389.CrossRefPubMed
19.
go back to reference Ogunbi SO, Ransom JA, Sullivan K, Schoen BT, Gold BD: Inflammatory bowel disease in African-American children living in Georgia. J Pediatr. 1998, 133: 103-107. 10.1016/S0022-3476(98)70187-8.CrossRefPubMed Ogunbi SO, Ransom JA, Sullivan K, Schoen BT, Gold BD: Inflammatory bowel disease in African-American children living in Georgia. J Pediatr. 1998, 133: 103-107. 10.1016/S0022-3476(98)70187-8.CrossRefPubMed
20.
go back to reference Shapira M, Tamir A: Crohn's disease in the Kinneret sub-district, Israel, 1960-1990. Incidence and prevalence in different ethnic subgroups. Eur J Epidemiol. 1994, 10: 231-233. 10.1007/BF01730377.CrossRefPubMed Shapira M, Tamir A: Crohn's disease in the Kinneret sub-district, Israel, 1960-1990. Incidence and prevalence in different ethnic subgroups. Eur J Epidemiol. 1994, 10: 231-233. 10.1007/BF01730377.CrossRefPubMed
21.
go back to reference Al Salamah SM: Surgery for small bowel Crohn's disease: Experience of a tertiary referral center. Saudi J Gastro. 2005, 11: 85-92. 10.4103/1319-3767.33324.CrossRef Al Salamah SM: Surgery for small bowel Crohn's disease: Experience of a tertiary referral center. Saudi J Gastro. 2005, 11: 85-92. 10.4103/1319-3767.33324.CrossRef
22.
go back to reference Alic M: Inflammatory bowel diseases are diseases of higher socioeconomic status: dogma or reality?. Am J Gastroenterol. 2000, 95: 3332-3333. 10.1111/j.1572-0241.2000.03330.x.CrossRefPubMed Alic M: Inflammatory bowel diseases are diseases of higher socioeconomic status: dogma or reality?. Am J Gastroenterol. 2000, 95: 3332-3333. 10.1111/j.1572-0241.2000.03330.x.CrossRefPubMed
23.
go back to reference Aysel U, Erkan P, Ulku D, Tezel AD, Canan A, Burhan : Epidemiology of Inflammatory Bowel Disease. Turk J Gastro. 1999, 10: 55-59. Aysel U, Erkan P, Ulku D, Tezel AD, Canan A, Burhan : Epidemiology of Inflammatory Bowel Disease. Turk J Gastro. 1999, 10: 55-59.
24.
go back to reference Steury EM, Templeton AC: Crohn's disease in Africa. A case report and review. Trop Geogr Med. 1980, 32: 172-173.PubMed Steury EM, Templeton AC: Crohn's disease in Africa. A case report and review. Trop Geogr Med. 1980, 32: 172-173.PubMed
25.
go back to reference Economou M, Zambeli E, Michopoulos S: Incidence and prevalence of Crohn's disease and its etiological influences. Annals of Gasteroenterology. 2009, 22: 158-167. Economou M, Zambeli E, Michopoulos S: Incidence and prevalence of Crohn's disease and its etiological influences. Annals of Gasteroenterology. 2009, 22: 158-167.
26.
go back to reference McKinnon J: The Black Population in the United States: March 2002. Population Characteristics. 2003, U.S. Department of Commerce Economics and Statistics Administration Economics and Statistics Administration. Ref Type: Report McKinnon J: The Black Population in the United States: March 2002. Population Characteristics. 2003, U.S. Department of Commerce Economics and Statistics Administration Economics and Statistics Administration. Ref Type: Report
27.
go back to reference Edwards CN, Griffith SG, Hennis AJ, Hambleton IR: Inflammatory bowel disease: incidence, prevalence, and disease characteristics in Barbados, West Indies. Inflamm Bowel Dis. 2008, 14: 1419-1424. 10.1002/ibd.20495.CrossRefPubMed Edwards CN, Griffith SG, Hennis AJ, Hambleton IR: Inflammatory bowel disease: incidence, prevalence, and disease characteristics in Barbados, West Indies. Inflamm Bowel Dis. 2008, 14: 1419-1424. 10.1002/ibd.20495.CrossRefPubMed
28.
go back to reference Kurata JH, Kantor-Fish S, Frankl H, Godby P, Vadheim CM: Crohn's disease among ethnic groups in a large health maintenance organization. Gastroenterology. 1992, 102: 1940-1948.CrossRefPubMed Kurata JH, Kantor-Fish S, Frankl H, Godby P, Vadheim CM: Crohn's disease among ethnic groups in a large health maintenance organization. Gastroenterology. 1992, 102: 1940-1948.CrossRefPubMed
29.
go back to reference Finlay DG, Basu D, Sellin JH: Effect of race and ethnicity on perceptions of inflammatory bowel disease. Inflamm Bowel Dis. 2006, 12: 503-507. 10.1097/00054725-200606000-00010.CrossRefPubMed Finlay DG, Basu D, Sellin JH: Effect of race and ethnicity on perceptions of inflammatory bowel disease. Inflamm Bowel Dis. 2006, 12: 503-507. 10.1097/00054725-200606000-00010.CrossRefPubMed
30.
go back to reference Nguyen GC, Torres EA, Regueiro M, Bromfield G, Bitton A, Stempak J, et al: Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol. 2006, 101: 1012-1023. 10.1111/j.1572-0241.2006.00504.x.CrossRefPubMed Nguyen GC, Torres EA, Regueiro M, Bromfield G, Bitton A, Stempak J, et al: Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol. 2006, 101: 1012-1023. 10.1111/j.1572-0241.2006.00504.x.CrossRefPubMed
31.
go back to reference Reddy SI, Burakoff R: Inflammatory bowel disease in African Americans. Inflamm Bowel Dis. 2003, 9: 380-385. 10.1097/00054725-200311000-00006.CrossRefPubMed Reddy SI, Burakoff R: Inflammatory bowel disease in African Americans. Inflamm Bowel Dis. 2003, 9: 380-385. 10.1097/00054725-200311000-00006.CrossRefPubMed
32.
go back to reference Goldman CD, Kodner IJ, Fry RD, MacDermott RP: Clinical and operative experience with non-Caucasian patients with Crohn's disease. Dis Colon Rectum. 1986, 29: 317-321. 10.1007/BF02554120.CrossRefPubMed Goldman CD, Kodner IJ, Fry RD, MacDermott RP: Clinical and operative experience with non-Caucasian patients with Crohn's disease. Dis Colon Rectum. 1986, 29: 317-321. 10.1007/BF02554120.CrossRefPubMed
33.
go back to reference Simsek H, Schuman BM: Inflammatory bowel disease in 64 black patients: analysis of course, complications, and surgery. J Clin Gastroenterol. 1989, 11: 294-298. 10.1097/00004836-198906000-00010.CrossRefPubMed Simsek H, Schuman BM: Inflammatory bowel disease in 64 black patients: analysis of course, complications, and surgery. J Clin Gastroenterol. 1989, 11: 294-298. 10.1097/00004836-198906000-00010.CrossRefPubMed
34.
go back to reference Basu D, Lopez I, Kulkarni A, Sellin JH: Impact of race and ethnicity on inflammatory bowel disease. Am J Gastroenterol. 2005, 100: 2254-2261. 10.1111/j.1572-0241.2005.00233.x.CrossRefPubMed Basu D, Lopez I, Kulkarni A, Sellin JH: Impact of race and ethnicity on inflammatory bowel disease. Am J Gastroenterol. 2005, 100: 2254-2261. 10.1111/j.1572-0241.2005.00233.x.CrossRefPubMed
35.
go back to reference Cucino C, Sonnenberg A: The comorbid occurrence of other diagnoses in patients with ulcerative colitis and Crohn's disease. Am J Gastroenterol. 2001, 96: 2107-2112. 10.1111/j.1572-0241.2001.03943.x.CrossRefPubMed Cucino C, Sonnenberg A: The comorbid occurrence of other diagnoses in patients with ulcerative colitis and Crohn's disease. Am J Gastroenterol. 2001, 96: 2107-2112. 10.1111/j.1572-0241.2001.03943.x.CrossRefPubMed
36.
go back to reference Buhner S, Buning C, Genschel J, Kling K, Herrmann D, Dignass A, et al: Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation?. Gut. 2006, 55: 342-347. 10.1136/gut.2005.065557.CrossRefPubMedPubMedCentral Buhner S, Buning C, Genschel J, Kling K, Herrmann D, Dignass A, et al: Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation?. Gut. 2006, 55: 342-347. 10.1136/gut.2005.065557.CrossRefPubMedPubMedCentral
37.
go back to reference Kugathasan S, Loizides A, Babusukumar U, McGuire E, Wang T, Hooper P, et al: Comparative phenotypic and CARD15 mutational analysis among African American, Hispanic, and White children with Crohn's disease. Inflamm Bowel Dis. 2005, 11: 631-638. 10.1097/01.MIB.0000171279.05471.21.CrossRefPubMed Kugathasan S, Loizides A, Babusukumar U, McGuire E, Wang T, Hooper P, et al: Comparative phenotypic and CARD15 mutational analysis among African American, Hispanic, and White children with Crohn's disease. Inflamm Bowel Dis. 2005, 11: 631-638. 10.1097/01.MIB.0000171279.05471.21.CrossRefPubMed
38.
go back to reference Ferrand PE, Fujimoto T, Chennathukuzhi V, Parry S, Macones GA, Sammel M, et al: The CARD15 2936insC mutation and TLR4 896 A > G polymorphism in African Americans and risk of preterm premature rupture of membranes (PPROM). Mol Hum Reprod. 2002, 8: 1031-1034. 10.1093/molehr/8.11.1031.CrossRefPubMed Ferrand PE, Fujimoto T, Chennathukuzhi V, Parry S, Macones GA, Sammel M, et al: The CARD15 2936insC mutation and TLR4 896 A > G polymorphism in African Americans and risk of preterm premature rupture of membranes (PPROM). Mol Hum Reprod. 2002, 8: 1031-1034. 10.1093/molehr/8.11.1031.CrossRefPubMed
39.
go back to reference Zaahl MG, Winter T, Warnich L, Kotze MJ: Analysis of the three common mutations in the CARD15 gene (R702W, G908R and 1007fs) in South African colored patients with inflammatory bowel disease. Mol Cell Probes. 2005, 19: 278-281. 10.1016/j.mcp.2005.03.001.CrossRefPubMed Zaahl MG, Winter T, Warnich L, Kotze MJ: Analysis of the three common mutations in the CARD15 gene (R702W, G908R and 1007fs) in South African colored patients with inflammatory bowel disease. Mol Cell Probes. 2005, 19: 278-281. 10.1016/j.mcp.2005.03.001.CrossRefPubMed
40.
go back to reference Russell RK, Drummond HE, Nimmo EE, Anderson N, Smith L, Wilson DC, et al: Genotype-phenotype analysis in childhood-onset Crohn's disease: NOD2/CARD15 variants consistently predict phenotypic characteristics of severe disease. Inflamm Bowel Dis. 2005, 11: 955-964. 10.1097/01.MIB.0000183423.38037.f3.CrossRefPubMed Russell RK, Drummond HE, Nimmo EE, Anderson N, Smith L, Wilson DC, et al: Genotype-phenotype analysis in childhood-onset Crohn's disease: NOD2/CARD15 variants consistently predict phenotypic characteristics of severe disease. Inflamm Bowel Dis. 2005, 11: 955-964. 10.1097/01.MIB.0000183423.38037.f3.CrossRefPubMed
41.
go back to reference Stenson WF, Snapper SB: Challenges in IBD research: Assessing progress and rethinking the research agenda. Inflamm Bowel Dis. 2008, 14: 687-708. 10.1002/ibd.20371.CrossRefPubMed Stenson WF, Snapper SB: Challenges in IBD research: Assessing progress and rethinking the research agenda. Inflamm Bowel Dis. 2008, 14: 687-708. 10.1002/ibd.20371.CrossRefPubMed
42.
go back to reference Freeman HJ: Use of the Crohn's disease activity index in clinical trials of biological agents. World J Gastroenterol. 2008, 14: 4127-4130. 10.3748/wjg.14.4127.CrossRefPubMedPubMedCentral Freeman HJ: Use of the Crohn's disease activity index in clinical trials of biological agents. World J Gastroenterol. 2008, 14: 4127-4130. 10.3748/wjg.14.4127.CrossRefPubMedPubMedCentral
43.
go back to reference Nikolaus S, Schreiber S: Diagnostics of inflammatory bowel disease. Gastroenterology. 2007, 133: 1670-1689. 10.1053/j.gastro.2007.09.001.CrossRefPubMed Nikolaus S, Schreiber S: Diagnostics of inflammatory bowel disease. Gastroenterology. 2007, 133: 1670-1689. 10.1053/j.gastro.2007.09.001.CrossRefPubMed
44.
go back to reference Bousvaros A, Antonioli DA, Colletti RB, Dubinsky MC, Glickman JN, Gold BD, et al: Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr. 2007, 44: 653-674. 10.1097/MPG.0b013e31805563f3.CrossRefPubMed Bousvaros A, Antonioli DA, Colletti RB, Dubinsky MC, Glickman JN, Gold BD, et al: Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr. 2007, 44: 653-674. 10.1097/MPG.0b013e31805563f3.CrossRefPubMed
45.
go back to reference Kugathasan S, Nebel J, Skelton JA, Markowitz J, Keljo D, Rosh J, et al: Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. J Pediatr. 2007, 151: 523-527. 10.1016/j.jpeds.2007.04.004.CrossRefPubMed Kugathasan S, Nebel J, Skelton JA, Markowitz J, Keljo D, Rosh J, et al: Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. J Pediatr. 2007, 151: 523-527. 10.1016/j.jpeds.2007.04.004.CrossRefPubMed
46.
go back to reference Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ, et al: The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007, 5: 1424-1429. 10.1016/j.cgh.2007.07.012.CrossRefPubMed Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ, et al: The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007, 5: 1424-1429. 10.1016/j.cgh.2007.07.012.CrossRefPubMed
Metadata
Title
African-American inflammatory bowel disease in a Southern U.S. health center
Authors
Hemanth Veluswamy
Kunal Suryawala
Ankur Sheth
Shannon Wells
Erik Salvatierra
Walter Cromer
Ganta V Chaitanya
Annette Painter
Mihir Patel
Kenneth Manas
Ellenmarie Zwank
Moheb Boktor
Kondal Baig
Balaji Datti
Michael J Mathis
Alireza Minagar
Paul A Jordan
Jonathan S Alexander
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2010
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-10-104

Other articles of this Issue 1/2010

BMC Gastroenterology 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.